Suppressed Herbal Remedies in U.S. History
U.S. history reveals a systematic suppression of herbal remedies, particularly those rooted in Ayurveda and Eastern medicine, through regulatory crackdowns, professional monopolization, and economic forces favoring patentable pharmaceuticals over ancient, non-proprietary plants. From colonial dismissal of indigenous knowledge to modern FDA classifications that burden cheap herbs with impossible trial requirements, this pattern prioritizes profits from chronic illness over cures. Ayurveda, India’s 5,000-year-old system emphasizing balance via herbs like turmeric and ashwagandha, and Eastern traditions like Traditional Chinese Medicine (TCM) with wormwood, faced double marginalization: first abroad under colonial rule, then in America via cultural bias and legal barriers. This article explores key eras, cases, and implications, drawing on historical patterns of gatekeeping that echo the Nobel-winning wormwood story—while proposing reforms that mirror history’s lessons to dismantle this entrenched suppression.
Colonial Foundations: Dismissing Eastern and Indigenous Herbs
America’s suppression of herbal remedies began with European settlers viewing non-Western systems as primitive superstition. Ayurveda and Eastern medicine entered indirectly via trade and immigration, but colonial mindsets—mirroring British policies in India—deemed them inferior to “scientific” European allopathy.
Native American herbalism, akin to Ayurveda’s holistic dosha balance, used willow bark (salicin source for aspirin) for pain, echinacea for immunity, and goldenseal for infections. Colonizers labeled these “savage cures,” eroding them through forced assimilation policies that prioritized Western care. Smallpox inoculation via pus-powdered scabs predated Jenner’s vaccine, yet was buried as primitive despite effectiveness.
Ayurveda’s U.S. entry traces to 19th-century Theosophists and transcendentalists like Thoreau, who praised Hindu texts for turmeric’s anti-inflammatory wisdom. British colonialism set precedents: Macaulay’s 1835 Minute on Indian Education defunded Ayurvedic teaching, calling it “nonsense”—a blueprint U.S. elites later adopted. Eastern medicine fared similarly; Chinese immigrants brought ginseng and ginger for digestion, but 1882 Chinese Exclusion Act xenophobia quarantined TCM as “filthy heathenism.”
By 1900, eclectic U.S. physicians blended Native, African, and Eastern herbs—sassafras from Ayurveda-inspired blood purification—but the AMA’s formation (1847) branded them irregulars, paving suppression.
19th-Century Botanical Wars: Thomsonianism vs. Allopathy
The 1800s saw U.S. botanical systems clash with heroically toxic allopathy, incorporating Ayurvedic and Eastern imports via global trade. Samuel Thomson’s system (1813) empowered laypeople with steam baths, cayenne, and lobelia (Eastern fever remedies) against calomel/mercury purgatives rotting jaws. Thomsonians self-published herbals with Eastern-influenced myrrh for “cold fevers.” By 1830s, 100+ societies thrived, but AMA labeled it quackery, lobbying states to criminalize practice without MD degrees.
Hydropathy integrated Ayurvedic Panchakarma-like detoxification; magnetic healing drew from TCM qi. Eastern herbs like ginger treated cholera outbreaks allopathy failed. Yet, 1840s licensing laws jailed herbalists. Ayurveda trickled in via Unitarians; Emerson studied Charaka Samhita, promoting turmeric. But Flexner loomed. More information – 19th-Century Botanical Wars: Thomsonianism vs. Allopathy
Flexner Report (1910): Rockefeller’s Pharma Pivot Buries Ayurveda and Eastern Herbs
Abraham Flexner’s Carnegie/Rockefeller-funded report closed 80% of schools teaching botanicals, homeopathy, or eclecticism—many offering Ayurveda/TCM courses. John D. Rockefeller poured $100M into allopathy, patenting petrochemical drugs. Herbal schools like Eclectic Medical College taught Ayurvedic neem for skin, ginseng for vitality—shuttered. By 1920s, only pharma-aligned MDs survived.
Eastern medicine suffered: TCM’s ephedra co-opted as ephedrine, but whole herb later banned. Ayurveda’s triphala ignored despite anti-parasitic efficacy paralleling wormwood. Rockefeller Institute dismissed Native willow until isolating salicin. Insurance shifted to allopaths, bankrupting herbalists.
Patent Medicine Era and 1906 Pure Food Act
Pre-1906, herbal cure-alls boomed: Hamlin’s Wizard Oil blended Eastern capsicum with Native sarsaparilla. Ayurvedic-inspired tonics used sarsaparilla. The Act banned opium-laced tonics but ensnared legitimate Eastern/Ayurvedic blends. FDA classified herbs “new drugs” needing proof—impossible for non-profits. Wormwood absinthe banned 1912 despite TCM use.
Great Depression to WWII: Economic Squeeze
Depression revived ginseng teas; AMA/FDA raids intensified via 1938 FD&C Act. WWII penicillin shortage revived asafetida (Eastern anti-flu). Ayurvedic turmeric studied for wounds but shelved for antibiotics. Japanese internment buried Kampo.
Post-WWII McCarthyism: Red Scare Hits Eastern Medicine
1950s AMA campaigns called herbalists “frauds.” Harry Hoxsey’s herbal cancer tonics (burdock, red clover—Ayurvedic) drew raids despite testimonials.
1960s-1980s: Counterculture Revival and Crackdown
1970s Ayurveda via Maharishi; Vasant Lad’s institute taught panchakarma, but FDA seized bhasmas. 1980s Wilk v. AMA exposed conspiracy. TCM boomed post-Nixon; wormwood vindicated 2015. FDA warned Artemisia toxicity.
DSHEA 1994: Partial Victory, Ongoing Suppression
DSHEA legalized supplements, boosting turmeric sales. But disease claims banned; heavy metal scares justified warnings. NCCIH funds skimpy trials.
Modern Examples: Ayurveda and Eastern Herbs Under Siege
Turmeric: 100+ studies ignored by FDA. Ashwagandha: COVID promising, seizures. Wormwood: Kills parasites, FDA “poison.” Ginseng: Limited. Neem: EPA squelched.
Economic Incentives: Non-Patentable = Suppressed
Herbs cheap; pharma lobbies $300M/year. Flexner legacy ignores Ayurveda in curricula.
Reforms Mirror History’s Lessons
These policy demands directly address suppression patterns, restoring access to Ayurveda, Eastern herbs, and holistic cures buried by profit-driven gatekeeping:
- Informed Consent, No More Human Experiments, No More Emergency Orders, No More Warp Speed Operations
Mandate full, transparent disclosure of all risks before any treatment; ban non-consensual human trials, end emergency orders and warp speed operations bypassing oversight, and require Big Pharma to prove safety first—stopping patients as unwitting guinea pigs. - Hold All Accountable for False Information
Hold all medical personnel, politicians, government employees/subcontractors, and media accountable for false or misleading statements about holistic cures and Big Pharma drugs—which are little more than ads—through strict penalties and legal consequences. - End Big Pharma Advertising, Lobbying, and Revolving Door
Ban all direct-to-consumer pharmaceutical advertising, prohibit lobbying of politicians by Big Pharma, and end the revolving door with Big Pharma and politicians, FDA, CDC, and other agencies—severing the profit-driven influence over public health policy. - Hold Non-Profits and Scientists Accountable for Deception
Penalize non-profits and scientists that knowingly provide false information or hide truthful data benefiting their donors, ensuring transparency and stripping tax-exempt status or funding for those prioritizing funders over public health. - NO MORE IMMUNITY FOR BIG PHARMA
End blanket liability shields letting pharmaceutical giants evade accountability for harmful drugs and vaccines—profits must not trump safety. - End Trial Requirements for Non-Patentable Therapies
Scrap mandates for cheap or natural remedies the market ignores, giving patients access without profit-driven delays. - Real Education for Doctors
Elevate nutrition, lifestyle, and integrative medicine in training to match drugs and procedures—not as afterthoughts. - Pay for Outcomes, Not Volume
Reward curing patients and preventing illness, not endless visits, tests, and procedures. - Truthful Claims for Honest Products
Allow evidence-backed statements for non-patentable therapies—modern studies or historical use—while banning fraud.
These reforms end the Flexner-era burial of Ayurveda and Eastern wisdom, validating wormwood’s legacy and empowering patients over pharma profits.